相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia
Mikkel Hojlund et al.
JAMA PSYCHIATRY (2022)
Preventing relapse in schizophrenia needs better evidence
Giovanni Ostuzzi et al.
LANCET (2022)
Antipsychotics and schizophrenia, tolerance first
[Anonymous]
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants
Giovanni Ostuzzi et al.
WORLD PSYCHIATRY (2022)
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
Christoph U. Correll et al.
SCHIZOPHRENIA (2022)
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis
Giovanni Ostuzzi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis
Dan Siskind et al.
SCHIZOPHRENIA BULLETIN (2021)
Switching antipsychotics to support the physical health of people with severe mental illness: a qualitative study of healthcare professionals' perspectives
Annabel Nash et al.
BMJ OPEN (2021)
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Mark Abie Horowitz et al.
SCHIZOPHRENIA BULLETIN (2021)
Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis
Pruntha Kanagasundaram et al.
FRONTIERS IN PSYCHIATRY (2021)
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia A Meta-analysis
Stefan Leucht et al.
JAMA PSYCHIATRY (2021)
Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis
Helene Speyer et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
Hideaki Tani et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review
Joanna Moncrieff et al.
SCHIZOPHRENIA RESEARCH (2020)
Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders
Rajeev Ayyagari et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. A systematic review and meta-analysis
Jan P A M Bogers et al.
SCHIZOPHRENIA BULLETIN (2020)
The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples
Wolfgang Gaebel et al.
SCHIZOPHRENIA RESEARCH (2020)
Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis
Javier Labad et al.
SCHIZOPHRENIA RESEARCH (2020)
Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis
Taro Kishi et al.
PSYCHOLOGICAL MEDICINE (2019)
Mental health professionals' views and experiences of antipsychotic reduction and discontinuation
Ruth E. Cooper et al.
PLOS ONE (2019)
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
Joanna Moncrieff et al.
BMJ OPEN (2019)
Stopping and switching antipsychotic drugs
Nicholas Keks et al.
AUSTRALIAN PRESCRIBER (2019)
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Peter M. Haddad et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2018)
Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis
Andrew Thompson et al.
EARLY INTERVENTION IN PSYCHIATRY (2016)
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2014)
Switching Antipsychotic Medications to Reduce Adverse Event Burden in Schizophrenia: Establishing Evidence-Based Practice
John W. Newcomer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
John M. Kane et al.
WORLD PSYCHIATRY (2013)
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Stefan Leucht et al.
LANCET (2012)
Adverse events associated with switching antipsychotics
Johnny Su
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
Undue reliance on I2 in assessing heterogeneity may mislead
Gerta Ruecker et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
An unadjusted NNT was a moderately good predictor of health benefit
CAKY Chong et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)